RT @AlegreCebollada: An example of the importance of genetic screening in hypertrophic cardiomyopathy. 40% of young carriers will develop t…
@IntervUfro
RT @AlegreCebollada: An example of the importance of genetic screening in hypertrophic cardiomyopathy. 40% of young carriers will develop t…
RT @AlegreCebollada: An example of the importance of genetic screening in hypertrophic cardiomyopathy. 40% of young carriers will develop t…
RT @AlegreCebollada: An example of the importance of genetic screening in hypertrophic cardiomyopathy. 40% of young carriers will develop t…
An example of the importance of genetic screening in hypertrophic cardiomyopathy. 40% of young carriers will develop the disease in the following 15 years. https://t.co/58Jhngoygn
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
Another study to highlight the key role of #CMR in the diagnosis of HCM, especially in genotype positive patients with a “normal” echo. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers - PubMed https://t.co/ZQKxKsOuCk
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers. https://t.co/hXTWjzSzWt
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
RT @vass_vassiliou: 50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst…
50% of those with a sarcomere mutation develop HCM...regular #WhyCMR follow up suggested! #epeeps #cardioed #echofirst @purviparwani @AlexFrogoudaki @MasriAhmadMD @GARCIAEDINSON95 @justvick @rahatheart1 @drjasondungu @aayshacader @VietHeartPA @AdeMarvao @c
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
RT @JACCJournals: In patients with sarcomere protein mutations, how many ultimately develop hypertrophic cardiomyopathy? Find out in this w…
RT @judbacke: Penetrance of HCMP in Sarcomere Protein Mutation Carriers - important message for #geneticcounseling in @JACCjournals this…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
Mi próximo seminario ❤️😍
RT @CSHeartResearch: ❤️Proud father moment... first publication with my daughter... editorial @JACCJournals on variable penetrance in hyper…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @ProtonotariosA: Congratulations to Max Lorenzini and the rest of our group for this work supporting the long-term follow-up of relative…
RT @ProtonotariosA: Congratulations to Max Lorenzini and the rest of our group for this work supporting the long-term follow-up of relative…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @colleencaleshu: We have so few studies on penetrance in #cardiogen, great to see this paper helping provide more evidence. #GCchat
RT @CSHeartResearch: ❤️Proud father moment... first publication with my daughter... editorial @JACCJournals on variable penetrance in hyper…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @robcoops82: Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers | JACC: Journal of the American College of…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
Following first negative screening, 50% of SP mutation carriers develop HCM over 15 years of fFU. Male sex and an abnormal ECG are associated with a higher risk of developing HCM. Regular CMR should be considered in long-term screening. https://t.co/zpvPRT
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
RT @JACCJournals: In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cv…
In genetic testing for hypertrophic cardiomyopathy (HCM), about 50% of those with sarcomere protein mutations develop #cvHCM over 15 years – should we be screening more with #MRI? https://t.co/VPMNA2YiXW #JACC https://t.co/LoM4Srv1mH
Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers | JACC: Journal of the American College of Cardiology https://t.co/ATh2JfW8Ru
RT @judbacke: Penetrance of HCMP in Sarcomere Protein Mutation Carriers - important message for #geneticcounseling in @JACCjournals this…
RT @MarcosCicerchia: 🧬❤️50% of patients with sarcomere protein gene mutations associated with HCM who do not meet diagnostic criteria for H…
RT @MarcosCicerchia: 🧬❤️50% of patients with sarcomere protein gene mutations associated with HCM who do not meet diagnostic criteria for H…
RT @CSHeartResearch: ❤️Proud father moment... first publication with my daughter... editorial @JACCJournals on variable penetrance in hyper…
RT @MarcosCicerchia: 🧬❤️50% of patients with sarcomere protein gene mutations associated with HCM who do not meet diagnostic criteria for H…
RT @robcoops82: Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers | JACC: Journal of the American College of…
RT @robcoops82: Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers | JACC: Journal of the American College of…
RT @CSHeartResearch: ❤️Proud father moment... first publication with my daughter... editorial @JACCJournals on variable penetrance in hyper…
RT @judbacke: Penetrance of HCMP in Sarcomere Protein Mutation Carriers - important message for #geneticcounseling in @JACCjournals this…
CONGRATS @CSHeartResearch and Caitlin. An AMAZING experience. Way to go you two.
RT @CSHeartResearch: ❤️Proud father moment... first publication with my daughter... editorial @JACCJournals on variable penetrance in hyper…
Congratulations to Max Lorenzini and the rest of our group for this work supporting the long-term follow-up of relatives with sarcomere protein gene mutations. ECG is still a top tool in clinical cardiology. https://t.co/ZPRjfWv0Cr
RT @CSHeartResearch: ❤️Proud father moment... first publication with my daughter... editorial @JACCJournals on variable penetrance in hyper…
RT @robcoops82: Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers | JACC: Journal of the American College of…
RT @MarcosCicerchia: 🧬❤️50% of patients with sarcomere protein gene mutations associated with HCM who do not meet diagnostic criteria for H…
RT @CSHeartResearch: ❤️Proud father moment... first publication with my daughter... editorial @JACCJournals on variable penetrance in hyper…
RT @robcoops82: Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers | JACC: Journal of the American College of…
RT @MarcosCicerchia: 🧬❤️50% of patients with sarcomere protein gene mutations associated with HCM who do not meet diagnostic criteria for H…
~50% +Sacromeric mutation carriers (median age 14) w/ initial negative screen develop #HCM over ~15 yrs. Takeaway: pretty decent penetrance, importance of #MRI f/u, abnormal ECG ⬆️⬆️ risk. Would longer f/u ⬆️ rate? #cardiotwitter #medtwitter #cardiogen h
RT @LuisRLopesDr: Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers https://t.co/PmJA6KTNCr @jpkaski @OchoaJ…
RT @CSHeartResearch: ❤️Proud father moment... first publication with my daughter... editorial @JACCJournals on variable penetrance in hyper…
RT @SantasEnrique: Penetrancia de miocardiopatía hipertrófica en 👥 portadores de mutación sarcomérica ✔️ 46% de penetrancia en seguimiento…
RT @CSHeartResearch: ❤️Proud father moment... first publication with my daughter... editorial @JACCJournals on variable penetrance in hyper…
RT @MarcosCicerchia: 🧬❤️50% of patients with sarcomere protein gene mutations associated with HCM who do not meet diagnostic criteria for H…